Download - Society for Cardiothoracic Surgery

10 theBulletin
July 2012
St George’s
Valve Technology Symposium
Marjan Jahangiri
The St .George’s Valve Technology Symposium took place on14
and 15 April. It was in it’s eighth year and was held in
association with Charing Cross Symposium for the first time.
The emphasis was to review current controversies in the field
of aortic and valvular heart surgery in an ‘intimate’ forum
allowing for discussion between delegates and speakers of all
levels of expertise.
The first day was devoted to management of the diseases of the
aorta, including endovascular and hybrid procedures. The
presentations were delivered by cardiac and vascular surgeons,
igniting lively debates. Furthermore, neurological sequelae and
methods of prevention of neurological complications and
operative aspects were reviewed.
The second day was devoted to management of valvular heart
disease, in particular aortic valve. Novel imaging modalities and
their application to surgery were discussed in detail. Minimally
invasive aortic valve replacement and transcatheter aortic valve
implantation (TAVI) were discussed with results from the latest
trials and registries.
In addition, the value of trials was presented, aiming to raise
awareness of some of the significant limitations of this in
modern cardiac surgery. This was particularly important since
we are in an era of introducing and establishing new modalities
of treatment in cardiac surgery which can change the face we
practice for many years to come.
There were mannequins for practicing wire required skills and
TAVI. The valve conference attracted 250 national and
international delegates and the overall Charing Cross
Symposium attracted 3800 delegates.
We hope to see you in 2013.
Marjan Jahangiri